| Abstrakt: |
Keywords: Actinobacteria; Allergies; Allergy Research; Antiparasitics; Bacterial Polysaccharides; Bifidobacterium; Biological Factors; Breast Diseases and Conditions; Business; Chemokine Receptors; Chemokines; Chemotactic Factors; Cytokine Receptors; Cytokines; Food Companies; G-Protein-Coupled Receptors; Galectins; Gram-Positive Asporogenous Rods; Gram-Positive Bacteria; Gram-Positive Rods; Health and Medicine; Immunology; Inflammation Mediators; Intercellular Signaling Peptides and Proteins; Lectins; Mastitis; Membrane Proteins; Morinaga Milk Industry Co. Ltd.; Prebiotics; Proteins; Risk and Prevention; Skin Diseases and Conditions EN Actinobacteria Allergies Allergy Research Antiparasitics Bacterial Polysaccharides Bifidobacterium Biological Factors Breast Diseases and Conditions Business Chemokine Receptors Chemokines Chemotactic Factors Cytokine Receptors Cytokines Food Companies G-Protein-Coupled Receptors Galectins Gram-Positive Asporogenous Rods Gram-Positive Bacteria Gram-Positive Rods Health and Medicine Immunology Inflammation Mediators Intercellular Signaling Peptides and Proteins Lectins Mastitis Membrane Proteins Morinaga Milk Industry Co. Ltd. Prebiotics Proteins Risk and Prevention Skin Diseases and Conditions 358 358 1 09/11/23 20230914 NES 230914 2023 SEP 14 (NewsRx) -- By a News Reporter-Staff News Editor at Food Weekly News -- Morinaga Milk Industry Co. Ltd. (Tokyo, Japan) has been issued patent number 11730171, according to news reporting originating out of Alexandria, Virginia, by NewsRx editors. Also, the present inventors have found that when a bacterium of the genus Bifidobacterium such as Bifidobacterium breve is orally administered to a subject, the amount of Galectin-9 in breast milk increases. [Extracted from the article] |
